Lv5
1550 积分 2022-11-11 加入
Therapeutic advances in the Lp(a) battle: what do we know and what are the most awaited novelties in the field?
7天前
已完结
Lepodisiran: Effects on Lipoprotein(a) and Cardiovascular Outcomes in Adults with Elevated Lp(a)
7天前
已完结
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
7天前
已完结
A Review of the Clinical Pharmacology of Pelacarsen: A Lipoprotein(a)-Lowering Agent
8天前
已完结
Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models
9天前
已完结
Hepatic GPR75 exacerbates MASH through GNAI2-Dependent signaling
9天前
已关闭
Mouse Models in Aging Research
9天前
已完结
Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis
9天前
已完结
Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis
9天前
已完结
皖公网安备34019202002308
